← Back to news

Markets

Buffett’s Final $140 Billion Trade: Here’s Where All His Stock Is Going, and Who Got Left Out

Y

How Meta Platforms (META) Is Strengthening Its AI Infrastructure With Custom Chips and Massive Computing Expansion

Y

Timewise debuts new loyalty program and mobile app

Y

Mortgage and refinance rates today, Wednesday, July 15, 2026: Mortgage rates mostly higher

Y

Midwest burger chain targets California, taking on In-N-Out

Y

IBM's historic crash exposes a deeper tech divide: Chart of the Day

Y

Grocery Outlet restarts expansion with new California branches

Y

Elevance shuts down D.C. Medicaid business, eyes additional exits after passable Q2

Y

Boomeranging makes a comeback: Why employers are welcoming back former workers

Y

Bitcoin ETFs Are Seeing Massive Outflows, but the Price of HYPE Keeps Rising. Here's Why I'm Bullish on Hyperliquid.

Y

Best CD rates today, Wednesday, July 15, 2026: Earn up to 4.10% APY

Y

China's DeepSeek to raise fresh capital at $74 billion valuation ahead of onshore IPO, sources say

Y

The Vanguard S&P 500 ETF Is a Great Investment. But Is It Safe?

Y

What to Expect From Devon Energy’s Next Quarterly Earnings Report

Y

How Casey’s keeps outperforming its c-store and QSR peers

Y

Danone’s $1.2 Billion Huel Deal Faces U.K. Competition Probe

Y

The Stock Market Just Flashed a Clear Warning Sign. Here's What History Says Comes Next.

Y

Brent Futures Flip to Backwardation as Middle East Supply Risks Return

Y

Earnings Preview: What To Expect From Apollo Global Management’s Report

Y

Why Synopsys (SNPS) Is Doubling Down on AI Chip Design Software to Strengthen Its Long-Term Competitive Advantage

Y

What to Expect From Ball Corporation’s Next Quarterly Earnings Report

Y

Can Shiba Inu Reach $1 by 2027? The Answer Will Blow Your Mind.

Y

Can Penguin Solutions Be the Next 10X Stock?

Y

Logitech (LOGI) Becomes Official PC Peripherals Partner For Call of Duty: Modern Warfare 4

Y

Diamondback Energy (FANG) Is Amongst The Oversold NASDAQ Stocks Amid Oil Price Dip

Y

Viper Energy (VNOM) Completes Riverbend Oil and Gas IX Acquisition

Y

Hyperscale and Enterprise AI Demand Bodes Well For Equinix (EQIX)

Y

Here Is Why Mattel (MAT) Is Amongst The 10 Oversold NASDAQ Stocks To Invest In Right Now

Y

Susquehanna Reaffirms Positive Rating For Patterson-UTI Energy (PTEN)

Y

Core Scientific (CORZ) Continues To Benefit From Energy Consumption Trends Across Data Centers

Y

What Makes Methanex Corp. (MEOH) One of The Oversold NASDAQ Stocks to Buy Now

Y

Honeywell International (HON) Offers Potential With Automation Portfolio Outlook

Y

Susquehanna Upholds Positive Rating For Baker Hughes (BKR)

Y

Kimco Realty’s Quarterly Earnings Preview: What You Need to Know

Y

How Amazon (AMZN) Is Using Its Financial Strength to Accelerate AI and Cloud Infrastructure Expansion

Y

Nvidia vs Cerebras: Which Is the Better Discount AI Buy Now?

Y

Banks Are on a Goldilocks Run. Don’t Assume It Will Last.

Y

Sterling Infrastructure: America's Data Center Builder With A Still Long Runway

S

London BTC Company, CelLBxHealth, Anglo Asian Mining, Galliford Try, NextEnergy Solar Fund

Y

Gold Falls as Investors Weigh Inflation Outlook

Y

Here's What to Expect From Cummins’ Next Earnings Report

Y

Prosperity Partners secures majority growth investment from Lightyear

Y

STG Logistics completes bankruptcy restructuring

Y

Prediction: This Under-the-Radar Dividend Stock Is Going to Skyrocket After Aug. 4

Y

Is Definium Therapeutics, Inc. (DFTX) Stock a Biotech Opportunity After Positive DT120 Depression Trial Data?

Y

Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?

Y

Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?

Y

Is AtaiBeckley Inc. (ATAI) Stock a Psychedelic Medicine Opportunity Ahead of Phase 2 Results?

Y

Is Vistagen Therapeutics, Inc. (VTGN) Stock Facing New Challenges After PALISADE-4 Clinical Trial Results?

Y

Is Cybin D/B/A Helus Pharma (HELP) Stock a Psychedelic Medicine Opportunity Ahead of HLP003 Trial Results?

Y